Home > Cashflow Statement > CONCORD DRUGS

CONCORD DRUGS
Cash Flow from Operating Activities

    Back to Cashflow Statement
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3.72 Cr₹0.79 Cr₹1.66 Cr₹0.77 Cr

What is the latest Cash Flow from Operating Activities ratio of CONCORD DRUGS ?

The latest Cash Flow from Operating Activities ratio of CONCORD DRUGS is ₹3.72 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹3.72 Cr
Mar2024₹0.79 Cr
Mar2023₹1.66 Cr
Mar2022₹0.77 Cr

How is Cash Flow from Operating Activities of CONCORD DRUGS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹3.72 Cr
369.95
Mar2024 ₹0.79 Cr
-52.38
Mar2023 ₹1.66 Cr
114.86
Mar2022 ₹0.77 Cr -

Compare Cash Flow from Operating Activities of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹93.7 Cr -2.4% -1% -16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,944.0 Cr -2% 6% 9.6% Stock Analytics
DIVIS LABORATORIES ₹294,962.0 Cr -4% 22.9% 75.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,391.0 Cr -1.8% 1.8% 21.9% Stock Analytics
DR REDDYS LABORATORIES ₹115,267.0 Cr -0.4% 13.1% 13.7% Stock Analytics
CIPLA ₹112,620.0 Cr -0.9% 4.5% -8% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-2.4%

-1%

-16.2%

SENSEX

1.4%

12.8%

-1.7%


You may also like the below Video Courses